StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

Investment analysts at StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS) in a report released on Monday. The firm set a “hold” rating on the stock.

Milestone Scientific Stock Performance

Shares of NYSE MLSS opened at $0.97 on Monday. Milestone Scientific has a 1 year low of $0.52 and a 1 year high of $1.35. The firm has a market cap of $74.91 million, a price-to-earnings ratio of -9.70 and a beta of 0.89. The stock’s 50-day simple moving average is $0.78 and its 200-day simple moving average is $0.69.

Milestone Scientific (NYSE:MLSS) last announced its earnings results on Wednesday, May 15th. The company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $2.25 million for the quarter. Milestone Scientific had a negative return on equity of 93.64% and a negative net margin of 74.50%.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.